ABN401

ABN401 is a potent and selective ATP-competitive c-MET inhibitor (IC50: 10 nM) that demonstrates cytotoxic effects in MET-dependent cancer cells and suppresses c-MET phosphorylation in tumors. It is a valuable tool compound for investigating MET-driven oncogenesis in both in vitro and in vivo anti-cancer research.